Obstetrics & Gynaecology Search
Obstetrics & Gynaecology Obstetrics & Gynaecology
pelvic%20inflammatory%20disease
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Patient Education

  • Patient needs to be informed about the nature of the infection & the importance of taking the full course of medication
  • Counsel patients on possible complications of sexually transmitted infection (STI)
  • Inform the patient of the possible short-term effects of PID (eg tubo-ovarian abscess) as well as long-term consequence (eg infertility, ectopic pregnancy, chronic pelvic pain)
    • Incidence of long-term adverse effect of PID is directly related to the number of recurrences of PID
  • Patients should be advised to avoid unprotected sex until they & their partners have completed therapy & follow-up

Advise patients on how to lower their risk of acquiring sexually transmitted infections (STIs):

  • Tailor counseling to the patient’s specific risk factors
  • Abstinence, condom use
  • Careful selection of partners

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Scalp cooling device effective in reducing chemo-induced alopecia in breast cancer patients
Audrey Abella, 28 Dec 2018
Use of a scalp cooling device is effective in reducing alopecia or hair loss in patients with breast cancer who are undergoing neoadjuvant/adjuvant chemotherapy including anthracyclines* and taxanes**, according to studies presented at SABCS 2018.
Metabolic syndrome may affect survival outcomes in early breast cancer
Roshini Claire Anthony, 09 Jan 2019

Women with metabolic syndrome who are diagnosed with early breast cancer may have poorer survival outcomes, according to a study from Italy presented as a poster at SABCS 2018.